<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:03:46Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2760406" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:2760406</identifier>
        <datestamp>2010-03-01</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">8904907</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">1376</journal-id>
              <journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
              <journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
              <journal-title-group>
                <journal-title>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0893-133X</issn>
              <issn pub-type="epub">1740-634X</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC2760406</article-id>
              <article-id pub-id-type="pmcid">PMC2760406</article-id>
              <article-id pub-id-type="pmc-uid">2760406</article-id>
              <article-id pub-id-type="pmid">19458612</article-id>
              <article-id pub-id-type="pmid">19458612</article-id>
              <article-id pub-id-type="doi">10.1038/npp.2009.54</article-id>
              <article-id pub-id-type="manuscript">nihpa113592</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Miller</surname>
                    <given-names>Jeffrey M.</given-names>
                  </name>
                  <degrees>M.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brennan</surname>
                    <given-names>Kathleen G.</given-names>
                  </name>
                  <degrees>M.A.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Todd Ogden</surname>
                    <given-names>R.</given-names>
                  </name>
                  <degrees>Ph.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Oquendo</surname>
                    <given-names>Maria A.</given-names>
                  </name>
                  <degrees>M.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sullivan</surname>
                    <given-names>Gregory M.</given-names>
                  </name>
                  <degrees>M.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>John Mann</surname>
                    <given-names>J.</given-names>
                  </name>
                  <degrees>M.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Parsey</surname>
                    <given-names>Ramin V.</given-names>
                  </name>
                  <degrees>M.D., Ph.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>1</label>Department of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY</aff>
              <aff id="A2"><label>2</label>Department of Psychiatry, Columbia University, New York, NY</aff>
              <aff id="A3"><label>3</label>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY</aff>
              <author-notes>
                <corresp id="FN1">Address all correspondence to: Jeffrey M. Miller, M.D., 1051 Riverside Drive #42, New York, NY 10043, Tel: 212-543-6528, Fax: 212-543-6017, <email>jm2233@columbia.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>24</day>
                <month>6</month>
                <year>2009</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>20</day>
                <month>5</month>
                <year>2009</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>9</month>
                <year>2009</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>01</day>
                <month>3</month>
                <year>2010</year>
              </pub-date>
              <volume>34</volume>
              <issue>10</issue>
              <fpage>2275</fpage>
              <lpage>2284</lpage>
              <!--elocation-id from pubmed: 10.1038/npp.2009.54-->
              <permissions>
                <license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">
                  <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
                </license>
              </permissions>
              <abstract>
                <sec id="S1">
                  <title>Background</title>
                  <p id="P1">Several biological abnormalities in major depressive disorder (MDD) persist during episode remission, including altered serotonin neurotransmission, and may reflect underlying pathophysiology. We previously described elevated brain serotonin 1A (5-HT<sub>1A</sub>) receptor binding in antidepressant-naïve subjects with MDD within a major depressive episode (MDE) compared to healthy controls using positron emission tomography (PET). In the current study, we measured 5-HT<sub>1A</sub> receptor binding in unmedicated subjects with MDD during sustained remission, hypothesizing higher binding compared with healthy controls, and binding comparable to currently depressed antidepressant-naïve subjects, indicative of a biologic trait.</p>
                </sec>
                <sec id="S2">
                  <title>Methods</title>
                  <p id="P2">We compared 5-HT<sub>1A</sub> binding potential (BP<sub>F</sub>) assessed through PET scanning with [<sup>11</sup>C]WAY-100635 in 15 subjects with recurrent MDD in remission for ≥12 months and off antidepressant medication for ≥ six months, 51 healthy controls, and 13 antidepressant-naïve MDD subjects in a current MDE. Metabolite-corrected arterial input functions were acquired for estimation of BP<sub>F</sub>.</p>
                </sec>
                <sec id="S3">
                  <title>Results</title>
                  <p id="P3">Remitted depressed subjects had higher 5-HT<sub>1A</sub> BP<sub>F</sub> than healthy controls; this group difference did not vary significantly in magnitude across brain regions. 5-HT<sub>1A</sub> BP<sub>F</sub> was comparable in remitted and currently depressed subjects.</p>
                </sec>
                <sec id="S4">
                  <title>Conclusions</title>
                  <p id="P4">Elevated 5-HT<sub>1A</sub> BP<sub>F</sub> among subjects with remitted MDD appears to be a trait abnormality in MDD, which may underlie recurrent major depressive episodes. Future studies should evaluate the role of genetic and environmental factors in producing elevated 5-HT<sub>1A</sub> BP<sub>F</sub> and MDD, and examine whether 5-HT<sub>1A</sub> BP<sub>F</sub> is a vulnerability factor to MDEs that could have a role in screening high-risk populations for MDD.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>depression</kwd>
                <kwd>serotonin</kwd>
                <kwd>5-HT1A receptor</kwd>
                <kwd>remission</kwd>
                <kwd>PET</kwd>
                <kwd>trait</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="S5">
              <title>Introduction</title>
              <p id="P5">Biological abnormalities in major depressive disorder (MDD) that are trait phenomena may be more likely to be part of the etiology of MDD predisposing to recurrent episodes of major depression, in contrast to homeostatic mechanisms or stress responses occurring only during acute illness (<xref rid="R8" ref-type="bibr">Bhagwagar and Cowen, 2008</xref>). There is evidence of trait serotonergic abnormalities in MDD. Acute tryptophan depletion provokes depressive symptoms in remitted depressed subjects and in relatives of depressed subjects, an effect not seen in healthy controls (<xref rid="R56" ref-type="bibr">Ruhe <italic>et al</italic>, 2007</xref>). In addition, acute challenges with serotonergic agents such as citalopram or fenfluramine result in blunted neuroendocrine responses in remitted depressed subjects (<xref rid="R10" ref-type="bibr">Bhagwagar <italic>et al</italic>, 2002</xref>, <xref rid="R20" ref-type="bibr">Flory <italic>et al</italic>, 1998</xref>).</p>
              <p id="P6">The 5-HT<sub>1A</sub> receptor is located on the soma and proximal dendrites of serotonergic neurons in the brainstem raphe nuclei, where it serves as an auto-receptor, and postsynaptically in the cortex and terminal fields all over the brain (<xref rid="R1" ref-type="bibr">Aghajanian, 2002</xref>). We have previously reported that antidepressant-naïve (AN) MDD subjects during a major depressive episode (MDE) have higher 5-HT<sub>1A</sub> receptor binding <italic>in vivo</italic> than healthy controls as assessed by positron emission tomography (PET; outcome measure BP<sub>F</sub>, = B<sub>avail</sub>/K<sub>D</sub>, where B<sub>avail</sub> is the receptor density available for binding and 1/K<sub>D</sub> is the affinity of radioligand) (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>). This is consistent with reports of elevated 5-HT<sub>1A</sub> brain receptors in animal models of depression, including 5-HT<sub>1A</sub> elevations in mice bred for helplessness on the tail suspension test (<xref rid="R41" ref-type="bibr">Naudon <italic>et al</italic>, 2002</xref>) and hippocampal 5-HT<sub>1A</sub> elevations among behaviorally depressed cynomolgus macaques in a post-mortem quantitative receptor autoradiography study (<xref rid="R59" ref-type="bibr">Shively <italic>et al</italic>, 2007</xref>), although a PET imaging study by this group using the outcome measure BP<sub>P</sub> revealed discrepant findings (<xref rid="R58" ref-type="bibr">Shively <italic>et al</italic>, 2006</xref>). Studies of neuroendocrine responses to 5-HT<sub>1A</sub> receptor agonists in MDD have been inconsistent (reviewed in (<xref rid="R42" ref-type="bibr">Navines <italic>et al</italic>, 2007</xref>)). There are also discrepancies in PET imaging findings regarding 5-HT<sub>1A</sub> abnormalities in MDD (<xref rid="R15" ref-type="bibr">Drevets <italic>et al</italic>, 1999</xref>, <xref rid="R16" ref-type="bibr">Drevets <italic>et al</italic>, 2007</xref>, <xref rid="R23" ref-type="bibr">Hirvonen <italic>et al</italic>, 2008</xref>, <xref rid="R34" ref-type="bibr">Meltzer <italic>et al</italic>, 2004</xref>, <xref rid="R39" ref-type="bibr">Moses-Kolko <italic>et al</italic>, 2007b</xref>, <xref rid="R57" ref-type="bibr">Sargent <italic>et al</italic>, 2000</xref>); divergent findings may be partly related to methodological differences and patient samples (see discussion for further detail). Post-mortem studies of 5-HT<sub>1A</sub> receptor binding in depression and/or suicide have variously reported increases, no changes, or decreases (reviewed in (<xref rid="R64" ref-type="bibr">Stockmeier, 2003</xref>); see also (<xref rid="R11" ref-type="bibr">Boldrini <italic>et al</italic>, 2008</xref>)). To our knowledge, no post-mortem study has examined 5-HT<sub>1A</sub> receptor binding among subjects with remitted depression.</p>
              <p id="P7">A previous PET study found persistent 5-HT<sub>1A</sub> receptor abnormalities during remission from MDD among 14 male subjects compared to 18 controls using the outcome measure BP<sub>ND</sub> (<xref rid="R9" ref-type="bibr">Bhagwagar <italic>et al</italic>, 2004</xref>). In the current study, we assessed 5-HT<sub>1A</sub> binding among 15 remitted depressed subjects using cerebellar white matter as the reference region to estimate the outcome measure BP<sub>F</sub>. Based on our findings among currently depressed subjects, we hypothesized that 5-HT<sub>1A</sub> BP<sub>F</sub> would be higher in subjects with recurrent MDD in sustained remission compared with healthy controls, consistent with a trait abnormality. As a secondary aim, we hypothesized that 5-HT<sub>1A</sub> BP<sub>F</sub> would not differ significantly between subjects with MDD in sustained remission and AN subjects with MDD in a current MDE.</p>
              <p id="P8">In an exploratory manner, we genotyped subjects for a functional C-1019G promoter polymorphism of the 5-HT<sub>1A</sub> gene (<xref rid="R33" ref-type="bibr">Lemonde <italic>et al</italic>, 2003</xref>). The G allele has been associated with greater expression in raphe neuron cell cultures <italic>in vitro</italic> (<xref rid="R33" ref-type="bibr">Lemonde <italic>et al</italic>, 2003</xref>), with greater raphe nucleus binding <italic>in vivo</italic> (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>), with the diagnosis of MDD and with diminished response to antidepressant treatment (reviewed in (<xref rid="R32" ref-type="bibr">Le François <italic>et al</italic>, 2008</xref>). Therefore, while the current study was underpowered for genetic analyses, we explored the hypothesis that the G allele would be less frequent among remitted MDD subjects compared to current MDD subjects, among whom only a portion will eventually achieve remission.</p>
            </sec>
            <sec sec-type="methods|subjects" id="S6">
              <title>Patients and Methods</title>
              <sec id="S7">
                <title>Subjects</title>
                <p id="P9">15 subjects who met criteria for MDD in full remission, 51 healthy controls, and 13 AN currently depressed subjects with MDD were included. This study draws on PET data from 42 healthy controls and 13 AN currently depressed MDD patients from a previous study (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>); those subjects underwent PET scanning between 7/29/1999 and 3/25/2003. In the present study, 15 subjects with MDD in full remission and a second cohort of nine healthy controls underwent PET scanning with [<sup>11</sup>C]WAY-100635 to quantify 5-HT<sub>1A</sub> receptor binding. Remitted depressed subjects were scanned between 2/3/2004 and 12/11/2007; the second cohort of controls was scanned between 5/24/2000 and 10/2/2007. Clinical assessments, PET acquisition, reconstruction, and image processing did not differ between groups. There was no evidence of drift in PET camera performance over the study period based on quality control measurements including cross calibration factor (in this assay, which is performed bimonthly, the HR+ scanner is calibrated using a cylindrical phantom filled with <sup>18</sup>F. The phantom is scanned using the HR+ for 30 minutes. Ten samples of the activity (2ml each) are taken from the phantom and measured in a Wallac 1480 Wizard well counter (PerkinElmer Lifescience). The cross calibration factor is the ratio of detected counts between the scanner and the well counter). After a comparison of first and second cohorts of healthy controls revealed no differences in 5-HT<sub>1A</sub> BP<sub>F</sub> considering all regions of interest (F=0.38, df=1,49, p=0.54), these cohorts were combined in subsequent analyses. Subjects were recruited through community advertisements; remitted depressed subjects were already in remission at the time of recruitment. Eligibility was assessed by psychiatric and medical history, chart review, Structured Clinical Interview for DSM-IV (SCID) (<xref rid="R19" ref-type="bibr">First <italic>et al</italic>, 1995</xref>), physical examination, routine blood tests, pregnancy test, and urine toxicology. The Beck Depression Inventory (BDI) (<xref rid="R6" ref-type="bibr">Beck <italic>et al</italic>, 1961</xref>), Hamilton Depression Rating Scale (HAM-D) (<xref rid="R22" ref-type="bibr">Hamilton, 1960</xref>), and Global Assessment Scale (GAS) (<xref rid="R18" ref-type="bibr">Endicott <italic>et al</italic>, 1976</xref>), and Beck Hopelessness Scale (<xref rid="R7" ref-type="bibr">Beck <italic>et al</italic>, 1974</xref>), assessed depression severity and functional impairment.</p>
                <p id="P10">Inclusion criteria for remitted depressed subjects were: 1) DSM-IV criteria for MDD, in full remission for at least one year; 2) ≥ two prior MDEs; 3) 17-item HAM-D &lt;8 upon screening; 4) absence of psychotropic medication use for ≥6 months before the PET scan (to minimize the effects of prior antidepressant treatment on 5-HT<sub>1A</sub> BP<sub>F</sub> (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>, <xref rid="R63" ref-type="bibr">Spindelegger <italic>et al</italic>, 2008</xref>)); 5) age 18–65 years; 6) no current or lifetime history of alcohol or other drug abuse or dependence; 7) absence of lifetime exposure to 3,4-methylenedioxymethamphetamine; 8) absence of significant current medical conditions; 9) absence of pregnancy; and 10) capacity to provide informed consent. We required a minimum of two prior MDEs given findings of greater biological abnormalities in recurrent as opposed to single episode MDD (<xref rid="R5" ref-type="bibr">Basso and Bornstein, 1999</xref>, <xref rid="R28" ref-type="bibr">Kupfer <italic>et al</italic>, 1991</xref>, <xref rid="R68" ref-type="bibr">Thase, 1992</xref>, <xref rid="R69" ref-type="bibr">Thase <italic>et al</italic>, 1995</xref>), with at least one difference persisting into remission (<xref rid="R25" ref-type="bibr">Jindal <italic>et al</italic>, 2002</xref>). Healthy controls met inclusion criteria five through ten, had no psychiatric history, and had no history of a mood or psychotic disorder in their first-degree relatives. AN subjects with current MDD met DSM-IV criteria for a current MDE and had never taken antidepressant medication; these subjects met inclusion criteria five through ten above. Comorbid disorders among remitted depressed subjects, which were in remission, included post-traumatic stress disorder (n=1) and attention-deficit hyperactivity disorder (n=1). Among AN currently depressed subjects, comorbid disorders included panic disorder (n=4), post-traumatic stress disorder (n=2), dysthymia (n=3), and social anxiety disorder (n=1). This study was approved by the Institutional Review Board of the New York State Psychiatric Institute. All subjects gave written informed consent after explanation of the study.</p>
              </sec>
              <sec id="S8">
                <title>Radiochemistry</title>
                <p id="P11">[<sup>11</sup>C]WAY100635 was prepared as previously described (<xref rid="R53" ref-type="bibr">Parsey <italic>et al</italic>, 2000</xref>). Remitted depressed subjects had lower mean injected dose and mass of [<sup>11</sup>C]WAY100635 than healthy controls (injected dose: remitted depressed = 4.6±1.2mCi, controls = 8.0±3.4mCi, T=3.75, DF=64, p = 0.0004; injected mass: remitted depressed = 1.7±1.6 μg, controls = 2.0±2.0μg, T=2.17, DF=64, p=0.033). This was intentional, as the majority of remitted depressed subjects were scanned following publication of a dosimetry study for [<sup>11</sup>C]WAY100635 recommending reductions in injected dose and mass for human studies (<xref rid="R47" ref-type="bibr">Parsey <italic>et al</italic>, 2005b</xref>). [<sup>11</sup>C]WAY100635 equilibrium distribution volume (V<sub>T</sub>) should be insensitive to changes in injected mass if receptor occupancy is below 10% (<xref rid="R60" ref-type="bibr">Slifstein and Laruelle, 2001</xref>). Indeed, there was not a significant correlation between injected mass or dose and V<sub>T</sub> in any region of interest (representative pre- and post-synaptic regions: raphe nucleus and injected mass: r=0.075, p=.51; raphe nucleus and injected dose: r=0.025, p=.82; hippocampus and injected mass: r=0.14, p=.20; hippocampus and injected dose: r=0.11, p=.36).</p>
                <p id="P12">Measurement of the arterial input function, plasma free fraction (<italic>f</italic><sub>P</sub>), and metabolites was conducted as described previously (<xref rid="R53" ref-type="bibr">Parsey <italic>et al</italic>, 2000</xref>). <italic>f<sub>P</sub></italic> was lower among remitted depressed than controls, but did not differ between remitted depressed and AN currently depressed subjects (remitted depressed = 0.062±0.026, controls = 0.081±0.024, t=2.66, df=64, p=0.01; AN currently depressed = 0.066±0.023; remitted vs. AN currently depressed: t=0.46, df=26, p=0.65).</p>
              </sec>
              <sec id="S9">
                <title>PET and MRI Acquisition</title>
                <p id="P13">After placement of an arterial and venous catheter, PET imaging was performed on an ECAT EXACT HR+ (Siemens/CTI, Knoxville, TN) (63 slices covering an axial field of view of 15.5 cm, axial sampling of 2.46 mm, in 3D mode. A 10 min transmission scan was acquired prior to injection of [<sup>11</sup>C]WAY-100635 as an i.v. bolus over 45 seconds. Emission data were collected for 110 minutes as 20 successive frames of increasing duration. Images were reconstructed using the 3D-RP algorithm implemented on a vector processor (CTI, Knoxville, TN) to a 128×128 matrix (pixel size of 1.7 × 1.7 mm<sup>2</sup>) with attenuation correction and a Shepp 0.5 filter (cutoff 0.5 cycles/projection rays) resulting in an in-plane and axial resolution (i.e. full width half-maximum) of 4.4 mm and 4.1 mm in air and at the center of the field of view (<xref rid="R12" ref-type="bibr">Brix <italic>et al</italic>, 1997</xref>). Scatter correction was performed using the technique implemented by the manufacturer (<xref rid="R70" ref-type="bibr">Watson <italic>et al</italic>, 1995</xref>).</p>
                <p id="P14">Acquisition of T1-weighted MRI for co-registration of PET images and identification of regions of interest was performed as previously described using a 1.5 T Signa Advantage or a 3 T Signa HDx system (General Electric Medical Systems, Milwaukee, WI) (<xref rid="R53" ref-type="bibr">Parsey <italic>et al</italic>, 2000</xref>).</p>
              </sec>
              <sec id="S10">
                <title>Image Analysis</title>
                <p id="P15">Image analysis was performed using MATLAB 2006b (The Mathworks, Natick, MA) with extensions to the following open source packages: Functional Magnetic Resonance Imaging of the Brain’s Linear Image Registration Tool (FLIRT) v5. (<xref rid="R24" ref-type="bibr">Jenkinson and Smith, 2001</xref>), Brain Extraction Tool (BET) v1.2 (<xref rid="R62" ref-type="bibr">Smith, 2002</xref>), as well as Statistical Parametric Mapping (SPM5) normalization (<xref rid="R3" ref-type="bibr">Ashburner and Friston, 1999</xref>) and segmentation routines (<xref rid="R4" ref-type="bibr">Ashburner and Friston, 2005</xref>). No attempt was made to correct for transmission-emission mismatch. To correct for subject motion, de-noising filter techniques were applied to all PET images starting at frame five. The eighth frame was used as a reference to which all other frames were aligned using rigid body FLIRT. Motion correction was assessed visually by comparing movies of pre- and post-motion correction scans. Motion was evaluated for drift between frames and across the entire scan duration, separately. A mean of motion corrected frames eight through eighteen for each subject was registered to that subject’s T1-weighted MRI using FLIRT.</p>
                <p id="P16">Regions of interest were hand drawn on individual subjects’ T1-weighted MRI images by experienced technicians trained to reliably approximate these regions using brain atlases (<xref rid="R17" ref-type="bibr">Duvernoy, 1991</xref>, <xref rid="R66" ref-type="bibr">Talairach and Tournoux, 1988</xref>) and published reports (<xref rid="R26" ref-type="bibr">Kates <italic>et al</italic>, 1997</xref>, <xref rid="R27" ref-type="bibr">Killiany <italic>et al</italic>, 1997</xref>). ROIs included the ventral prefrontal cortex (PFC), medial PFC, dorsolateral PFC, anterior cingulate, body of the cingulate (posterior to anterior cingulate), amygdala, hippocampus, parahippocampal gyrus, insular cortex, temporal cortex, parietal cortex, and occipital cortex. A fixed volume elliptical ROI (2 cm<sup>3</sup>) was placed on the raphe nuclei in the dorsal midbrain: a composite of mostly the dorsal and median raphe nuclei, on a mean PET image for each subject since the boundaries of this structure cannot be identified on MRI. A cylindrical ROI was drawn in the cerebellar white matter, which was used as the reference region for this study, as it has been previously shown to have the lowest concentration of 5-HT<sub>1A</sub> receptors within the cerebellum, and is adequately modeled by a one-tissue compartment model (<xref rid="R46" ref-type="bibr">Parsey <italic>et al</italic>, 2005a</xref>). For comparison purposes, a cylindrical ROI was drawn in the cerebellar gray matter. The segmented MRI image was used to refine the contours of the ROI to more accurately reflect the gyral pattern and differences between the PET and MRI fields of view.</p>
              </sec>
              <sec id="S11">
                <title>Quantitative Analysis</title>
                <p id="P17">Regional distribution volumes of [<sup>11</sup>C]WAY-100635 were derived from kinetic analysis using the arterial input function and a two tissue compartment (2T) model as the general framework (see (<xref rid="R53" ref-type="bibr">Parsey <italic>et al</italic>, 2000</xref>) for details). V<sub>ND</sub> and V<sub>S</sub> are defined as the distribution volumes of the nondisplaceable and specific compartments, respectively (<xref rid="R31" ref-type="bibr">Laruelle <italic>et al</italic>, 1994</xref>, <xref rid="R36" ref-type="bibr">Mintun <italic>et al</italic>, 1984</xref>). V<sub>T</sub>, the total regional equilibrium distribution volume, is equal to V<sub>ND</sub> + V<sub>S</sub>. The primary outcome measure for this study was binding potential (BP<sub>F</sub> = B<sub>avail</sub>/K<sub>D</sub>). Time activity curves were fit with a 2T model which has the K<sub>1</sub>/k<sub>2</sub> ratio fixed to that of the cerebellar white matter (reference region). BP<sub>F</sub> was calculated as (V<sub>T(ROI)</sub> − V<sub>T(CER)</sub>)/f<sub>P</sub> or (V<sub>T</sub> − V<sub>ND</sub>)/f<sub>P</sub>. For comparison purposes, the outcome measure BP<sub>ND</sub> was calculated using the simplified reference tissue model (SRTM) (<xref rid="R29" ref-type="bibr">Lammertsma and Hume, 1996</xref>), using both the cerebellar white and gray matter, as was the outcome measure BP<sub>P</sub> (= V<sub>T</sub> − V<sub>ND</sub> = f<sub>p</sub>B<sub>avail</sub>/K<sub>D</sub>). The contribution of plasma total activity to regional activity was calculated assuming a 5% blood volume in the ROI and was subtracted prior to analysis. Kinetic parameters were derived by nonlinear regression using a Levenberg-Marquart least squares minimization procedure implemented in MATLAB (The Math Works, Inc., South Natick, MA).</p>
              </sec>
              <sec id="S12">
                <title>Genotyping</title>
                <p id="P18">Genotyping of the C(-1019)G polymorphism of the 5-HT<sub>1A</sub> receptor gene was performed using allele-specific polymerase chain reaction (PCR) amplification as previously described (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>).</p>
              </sec>
              <sec id="S13">
                <title>Statistical Analysis</title>
                <p id="P19">To properly account for correlations among measurements made on the same subject, we applied mixed-effects modeling methods and analyzed the data for the 13 regions simultaneously, with region and diagnostic group as fixed effects and subject as the random effect. Standard errors (SE) were computed for each estimated <italic>BP</italic><sub>F</sub> value using a bootstrap algorithm that takes into account errors in metabolite, plasma, and brain data (<xref rid="R44" ref-type="bibr">Ogden and Tarpey, 2006</xref>). Observations were weighted accordingly in the linear mixed-effects models in order to increase precision in group estimates. Analyses were performed on natural log-transformed values. Log transformation is commonly used to remedy problems with skewness and unequal variance, both of which are generally issues with PET data. It has specifically been used in previous PET studies by our group and others to address these issues (<xref rid="R23" ref-type="bibr">Hirvonen <italic>et al</italic>, 2008</xref>, <xref rid="R35" ref-type="bibr">Miller <italic>et al</italic>, 2008</xref>, <xref rid="R45" ref-type="bibr">Oquendo <italic>et al</italic>, 2007</xref>, <xref rid="R48" ref-type="bibr">Parsey <italic>et al</italic>, 2006a</xref>, <xref rid="R49" ref-type="bibr">Parsey <italic>et al</italic>, 2006b</xref>, <xref rid="R50" ref-type="bibr">Parsey <italic>et al</italic>, 2006c</xref>, <xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>, <xref rid="R65" ref-type="bibr">Sullivan <italic>et al</italic>, 2005</xref>). Other groups have used related statistical approaches, including linearizing transformation (<xref rid="R55" ref-type="bibr">Rabiner <italic>et al</italic>, 2002b</xref>) and non-parametric testing (<xref rid="R34" ref-type="bibr">Meltzer <italic>et al</italic>, 2004</xref>) to address these issues in analyzing PET data. As the natural log is a monotone transformation, demonstrating a difference in log(BP<sub>F</sub>) is equivalent to demonstrating a difference (in the same direction) in BP<sub>F</sub>. <xref rid="F1" ref-type="fig">Figure 1</xref> presents raw BP<sub>F</sub> values. Reported p values were not adjusted for multiple comparisons. Linear mixed effects models of binding and Fisher’s exact tests were performed in R 2.1.0 (<ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org">http://cran.r-project.org</ext-link>). T-tests were performed in Excel (Microsoft, 2003).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="S14">
              <title>Results</title>
              <sec id="S15" sec-type="intro">
                <title>Clinical Characteristics</title>
                <p id="P20">Clinical characteristics of the study sample are presented in <xref rid="T1" ref-type="table">Table 1</xref>. The remitted MDD group had depression severity ratings that were modestly greater than healthy volunteers and only 10% that of the acutely depressed MDD group for the BDI. Both MDD groups had a comparable number of prior MDEs; the remitted group had been free from an episode for a mean of three years at the time of study participation. About 60% of both MDD groups had a first degree relative with MDD. Clinical assessments reported here were obtained within an average of 3.7±5.2 days of PET scanning.</p>
              </sec>
              <sec id="S16">
                <title>Comparison of 5-HT<sub>1A</sub> BP<sub>F</sub> Between Groups</title>
                <p id="P21">Remitted depressed subjects had higher 5-HT<sub>1A</sub> BP<sub>F</sub> than healthy controls including all brain regions in the model (<xref rid="F1" ref-type="fig">Figure 1</xref>; F=4.99, df=1,90, p=0.028). As we have found an inverse relationship between aggression (Brown-Goodwin Aggression scale) and 5-HT<sub>1A</sub> BP<sub>F</sub>, as well as a sex effect, with higher 5-HT<sub>1A</sub> BP<sub>F</sub> among females (<xref rid="R52" ref-type="bibr">Parsey <italic>et al</italic>, 2002</xref>), sex and aggression score were included as covariates in linear mixed effects models. The difference between remitted depressed subjects and healthy controls remained statistically significant with inclusion of sex and aggression as covariates in the model (F=8.45, df=1,86, p=0.0046). The magnitude of difference between these groups did not vary across brain regions (region-by-diagnosis interaction: F=1.36, df=12,756, p=0.18).</p>
                <p id="P22">5-HT<sub>1A</sub> BP<sub>F</sub> did not differ between remitted MDD and AN acutely depressed MDD subjects (<xref rid="F1" ref-type="fig">Figure 1</xref>; F=0.065, df=1,90, p=0.80), even after inclusion of sex and aggression as covariates in the model (F=0.003, df=1,86, p=0.95). 5-HT<sub>1A</sub> BP<sub>F</sub> was higher among AN acutely depressed MDD subjects than the combined cohort of healthy controls (F=6.65, df=1,62, p=0.012), even after inclusion of sex and aggression as covariates in the model (F=7.51, df=1,58, p=0.0081).</p>
              </sec>
              <sec id="S17">
                <title>Alternative Outcome Measures</title>
                <p id="P23">In order to compare our findings with other studies, we repeated the primary analysis comparing remitted depressed subjects to healthy controls using outcome measure BP<sub>ND</sub>, estimated via the simplified reference tissue method (<xref rid="R61" ref-type="bibr">Slifstein <italic>et al</italic>, 2000</xref>), consistent with methods used in a previous publication examining 5-HT<sub>1A</sub> binding in remitted depression (<xref rid="R9" ref-type="bibr">Bhagwagar <italic>et al</italic>, 2004</xref>). We performed this comparison using two different reference regions, cerebellar white matter and cerebellar gray matter. When using the cerebellar white matter as reference region, BP<sub>ND</sub> was an average of 11.4% higher across all regions of interest among remitted depressed subjects than controls, although this difference was not statistically significant (F=1.66, DF=1,61, p=0.20). In contrast, when the cerebellar gray matter was used as the reference region, which has appreciable 5-HT<sub>1A</sub> binding (<xref rid="R46" ref-type="bibr">Parsey <italic>et al</italic>, 2005a</xref>), BP<sub>ND</sub> was an average of 22.6% <italic>lower</italic> across all regions of interest among remitted depressed subjects than controls (F=10.78, DF=1,61, p=0.002). While the V<sub>T</sub> of the reference region used for our primary analyses, the cerebellar white matter, did not differ significantly between remitted depressed and control subjects (remitted depressed: 0.25±0.10, controls: 0.29±0.11, T=1.16, DF=64, p=0.25), there was a trend toward higher V<sub>T</sub> in the alternative reference region of cerebellar gray matter among remitted depressed subjects compared to controls (remitted depressed: 0.57±0.25, controls: 0.47±0.19, T=1.71, DF=64, p=0.092).</p>
                <p id="P24">When we re-analyzed our data using the outcome measure BP<sub>P</sub> (= V<sub>T</sub> − V<sub>ND</sub> = <italic>f</italic><sub>p</sub>B<sub>avail</sub>/K<sub>D</sub>), which requires the assumption of equivalent <italic>f</italic><sub>P</sub> between groups but which therefore does not require <italic>f</italic><sub>P</sub> measurement, using cerebellar white matter as the reference region, differences in 5-HT<sub>1A</sub> BP<sub>P</sub> between remitted depressed subjects and controls were not statistically significant (F=0.38, df=1,64, p=0.54).</p>
              </sec>
              <sec id="S18">
                <title>5-HT<sub>1A</sub> Receptor Promoter Polymorphism</title>
                <p id="P25">For genetic analysis, we included antidepressant-exposed with antidepressant-naïve currently depressed subjects from the currently depressed MDD cohort (described in (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>)), as prior medication status does not affect genotype, comparing these 28 currently depressed subjects with remitted depressed subjects and healthy volunteers for the C(-1019)G polymorphism in the 5-HT<sub>1A</sub> receptor gene. Considering all three groups simultaneously (healthy controls, remitted MDD, and currently depressed MDD), there was a difference in genotype between groups, with higher frequency of the GG genotype of the in the MDD groups (<xref rid="T2" ref-type="table">Table 2</xref>; Fisher’s exact, p=0.019). In pair-wise group comparisons of genotype frequency, the only two groups that differed significantly in genotype were currently depressed and control groups (Fisher’s exact, p=0.005); there were not significant differences between controls and remitted depressed (Fisher’s exact, p=0.54) or between remitted depressed and currently depressed groups (Fisher’s exact, p=0.23). The G allele was similarly more frequent in the current MDD group than the control group (Fisher’s exact, p=0.038).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="S19">
              <title>Discussion</title>
              <p id="P26">We find higher 5-HT<sub>1A</sub> BP<sub>F</sub> across all studied brain regions in subjects with recurrent MDD in sustained remission and off antidepressant medications for at least six months compared with healthy controls. In addition, we do not find a significant difference in 5-HT<sub>1A</sub> BP<sub>F</sub> between remitted and currently depressed MDD subjects. These findings are consistent with a trait abnormality in 5-HT<sub>1A</sub> receptor BP<sub>F</sub> in MDD.</p>
              <p id="P27">While the current findings may appear at odds with a report of lower 5-HT<sub>1A</sub> BP<sub>ND</sub> among remitted depressed subjects as compared to controls (<xref rid="R9" ref-type="bibr">Bhagwagar <italic>et al</italic>, 2004</xref>), that study used the entire cerebellum as the reference region, and estimated the outcome measure BP<sub>ND</sub>. Inclusion of the cerebellar vermis and gray matter in a reference region may lead to bias in resulting binding estimates, given detectable 5-HT<sub>1A</sub> binding in these subregions (<xref rid="R46" ref-type="bibr">Parsey <italic>et al</italic>, 2005a</xref>). Small differences in reference region distribution volume (V<sub>ND</sub>) can have large effects on BP<sub>ND</sub>, as BP<sub>ND</sub> is equal to (V<sub>T</sub>-V<sub>ND</sub>)/V<sub>ND</sub>, and V<sub>ND</sub> is typically &lt;1. When we re-analyzed our data using the cerebellar gray matter as reference region, estimating BP<sub>ND</sub> via the simplified reference tissue model, BP<sub>ND</sub> was an average of 22.6% <italic>lower</italic> across all regions of interest among remitted depressed subjects than controls, consistent with (<xref rid="R9" ref-type="bibr">Bhagwagar <italic>et al</italic>, 2004</xref>). In contrast, when BP<sub>ND</sub> was estimated using the cerebellar white matter as reference region, mean BP<sub>ND</sub> was 11.4% higher across all regions of interest among remitted depressed subjects than controls, although this difference was not statistically significant. This difference was driven by a trend toward higher V<sub>T</sub> in the alternative reference region of cerebellar gray matter among remitted depressed subjects compared to controls, consistent with our reports of appreciable 5-HT<sub>1A</sub> receptor binding in the cerebellar gray matter (<xref rid="R46" ref-type="bibr">Parsey <italic>et al</italic>, 2005a</xref>). This result reconciles seemingly disparate findings, and emphasizes the importance of considering specific methodology, including the reference region and outcome measure used, in interpreting PET findings (<xref rid="R53" ref-type="bibr">Parsey <italic>et al</italic>, 2000</xref>).</p>
              <p id="P28">We used BP<sub>F</sub> as the outcome measure in this study as it is the closest measure to B<sub>avail</sub> among the existing outcome measures for PET studies (BP<sub>F</sub>, BP<sub>P</sub>, and BP<sub>ND</sub>). However, estimating BP<sub>F</sub> requires measurement of <italic>f</italic><sub>P</sub>, which is particularly low with [<sup>11</sup>C]WAY-100635. When we re-analyzed our data using the outcome measure BP<sub>P</sub> (= V<sub>T</sub> − V<sub>ND</sub> = <italic>f</italic><sub>p</sub>B<sub>avail</sub>/K<sub>D</sub>), which requires the assumption of equivalent <italic>f</italic><sub>P</sub> between groups but which therefore does not require <italic>f</italic><sub>P</sub> measurement, 5-HT<sub>1A</sub> BP<sub>P</sub> was numerically higher among remitted depressed subjects than controls (an average of 9.2% higher across all regions of interest), although this difference was not statistically significant. This suggests that the observed difference in BP<sub>F</sub> between groups is partially dependent on <italic>f</italic><sub>P</sub>. We observed lower <italic>f</italic><sub>P</sub> among remitted depressed subjects than controls; we had previously found non-significantly lower f<sub>P</sub> among currently depressed subjects than controls (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>). If such a peripheral marker were found to reliably correlate (inversely) with cerebral 5-HT<sub>1A</sub> binding potential, it could be used clinically as a less invasive surrogate marker for cerebral 5-HT<sub>1A</sub> binding. However, there is significant overlap in [<sup>11</sup>C]WAY-100635 <italic>f</italic><sub>P</sub> between groups, and <italic>f</italic><sub>P</sub> is insensitive to regional heterogeneity in brain receptor binding. Of note, Hirvonen <italic>et al</italic> previously compared antidepressant-naïve currently depressed subjects to healthy controls using the outcome measure BP<sub>P</sub>, reporting lower 5-HT<sub>1A</sub> BP<sub>P</sub> among currently depressed subjects than controls (<xref rid="R23" ref-type="bibr">Hirvonen <italic>et al</italic>, 2008</xref>); that study did not examine remitted depressed subjects. Differences in methodology include their use of atlas-based methods for automated ROI labeling. In addition, it is possible that frequencies of the C-1019G 5-HT<sub>1A</sub> receptor polymorphism differed between samples, although this was not reported in their study, which may also have contributed to discrepant findings in comparing <italic>currently</italic> depressed subjects to controls.</p>
              <p id="P29">Our findings are consistent with broadly-distributed elevations in 5-HT<sub>1A</sub> receptor binding as a trait abnormality in MDD. Based on these results, we propose the following model to integrate several recent findings by our group and others regarding longitudinal 5-HT<sub>1A</sub> expression in major depression (<xref rid="F2" ref-type="fig">Figure 2</xref>). Due to genetics, childhood experiences, or gene-environment interactions, AN subjects with MDD have higher 5-HT<sub>1A</sub> BP<sub>F</sub> than healthy controls by the time of the onset of a first MDE. If this receptor difference is important causally, one would predict that 5-HT<sub>1A</sub> receptor differences precede the development of depressive symptomatology, a question for future study. Chronic treatment with antidepressants may then lead to reductions in 5-HT<sub>1A</sub> BP<sub>F</sub>, although data are not conclusive. We find lower 5-HT<sub>1A</sub> BP<sub>F</sub> among MDD subjects who have received previous antidepressant treatment compared with medication naïve MDD subjects, providing cross-sectional evidence of medication effects (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>). A reduction in 5-HT<sub>1A</sub> BP<sub>ND</sub> following ≥12 weeks of treatment with escitalopram was reported in subjects with social phobia or panic disorder, indicating receptor down-regulation with chronic SSRI use (<xref rid="R63" ref-type="bibr">Spindelegger <italic>et al</italic>, 2008</xref>). Consistent with these human findings, mice that have been stressed by housing in isolation show increased 5-HT<sub>1A</sub> receptor binding, which is reversed post-synaptically by chronic treatment with the SSRI citalopram (<xref rid="R21" ref-type="bibr">Gunther <italic>et al</italic>, 2008</xref>). In contrast, other human studies have not observed changes in 5-HT<sub>1A</sub> binding after shorter SSRI courses in major depression (<xref rid="R38" ref-type="bibr">Moses-Kolko <italic>et al</italic>, 2007a</xref>, <xref rid="R57" ref-type="bibr">Sargent <italic>et al</italic>, 2000</xref>). Finally, we find higher 5-HT<sub>1A</sub> BP<sub>F</sub> in remitted depressed subjects off antidepressant medications for a minimum of six months compared to controls, suggesting that 5-HT<sub>1A</sub> BP<sub>F</sub> increases again over time after stopping antidepressant medication, returning to elevated pre-treatment levels without return of MDE, and that it remains persistently elevated into remission among subjects not taking antidepressant medication.</p>
              <p id="P30">Trait elevations in 5-HT<sub>1A</sub> binding potential in MDD could be partly explained by a genetic model of over-representation of the G allele of the 5-HT<sub>1A</sub> C(-1019)G polymorphism among subjects with MDD (<xref rid="R2" ref-type="bibr">Albert, 2004</xref>). This would lead to higher 5-HT<sub>1A</sub> autoreceptor binding in the raphe nucleus (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>), leading to greater inhibition of serotonergic neuronal firing and decreased serotonin release in the terminal field of serotonin neurons, potentially leading to compensatory upregulation of 5-HT<sub>1A</sub> receptors in the terminal field. Whether less serotonin release related to this polymorphism would result in post-synaptic 5-HT<sub>1A</sub> receptor upregulation to compensate for serotonergic deficit is not known (<xref rid="R13" ref-type="bibr">Cahir <italic>et al</italic>, 2007</xref>), although a neurodevelopmental model would be required to test this hypothesis thoroughly.</p>
              <p id="P31">This genetic model is limited, as we did not observe an association between C(-1019)G polymorphism and 5-HT<sub>1A</sub> binding among the modest sample of remitted depressed subjects in the current study (f=1.34, df=2,9, p=0.31) although such an association was previously observed when considering a larger sample of 42 healthy controls and 28 currently depressed MDD subjects (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>). In addition, many subjects who develop MDD do not carry the G allele of this polymorphism, and differences in genotype frequency were only significant comparing <italic>currently</italic> depressed subjects to controls. The fact that allelic frequencies at this locus for remitted depressed subjects were intermediate between healthy controls and currently depressed subjects, but not significantly different from either group, may simply be due to the small size of this sample for genetic studies. Alternatively, while speculative, it is possible that subjects with MDD who achieve sustained remission have a lower frequency of the G allele than other MDD subjects (<xref rid="R32" ref-type="bibr">Le François <italic>et al</italic>, 2008</xref>), predisposing them to better antidepressant response and greater likelihood of sustained remission. Larger sample sizes are clearly needed to test this hypothesis thoroughly.</p>
              <p id="P32">While we did not observe region-by-diagnosis interactions when comparing remitted depressed subjects to either controls or AN currently depressed subjects, there are some regions in which remitted depressed 5-HT<sub>1A</sub> BP<sub>F</sub> appears closer to controls than to AN currently depressed subjects (<xref rid="F1" ref-type="fig">Fig 1</xref>). This suggests the need for replication studies with larger sample sizes to study whether 5-HT<sub>1A</sub> BP<sub>F</sub> may normalize partially in a regionally specific manner during sustained remission from MDD.</p>
              <p id="P33">There were some clinical and demographic differences between groups. Lifetime aggression (which has been associated with 5-HT<sub>1A</sub> BP<sub>F</sub>) was higher among remitted depressed subjects than controls. Differences in 5-HT<sub>1A</sub> BP<sub>F</sub> between remitted depressed and controls remained highly significant after aggression was included as a co-variate. The remitted depressed group had a higher proportion of Caucasian individuals than controls or AN currently depressed, and was more highly educated than the AN currently depressed group. There was also a trend toward a lower unemployment rate among remitted depressed than AN currently depressed (13% vs. 50%, p=0.08). These factors were all associated with a higher likelihood of remission with citalopram treatment in the STAR*D trial (Trivedi <italic>et al</italic>, 2006), consistent with the frequencies observed in our sample. While we are not aware of any studies reporting differences in 5-HT<sub>1A</sub> binding as a function of race or ethnicity, group differences in ethnicity may have affected allelic frequencies of the 5-HT<sub>1A</sub> receptor promoter polymorphism examined. Though not statistically significant, remitted depressed subjects were six years younger than healthy controls on average. We and others have previously found no effect of age on 5-HT<sub>1A</sub> binding (<xref rid="R52" ref-type="bibr">Parsey <italic>et al</italic>, 2002</xref>, <xref rid="R54" ref-type="bibr">Rabiner <italic>et al</italic>, 2002a</xref>, <xref rid="R57" ref-type="bibr">Sargent <italic>et al</italic>, 2000</xref>). Similarly, we found no correlation between age and 5-HT<sub>1A</sub> BP<sub>F</sub> in any region in the current cohort. While others have described age-related decline in 5-HT<sub>1A</sub> binding (<xref rid="R9" ref-type="bibr">Bhagwagar <italic>et al</italic>, 2004</xref>, <xref rid="R14" ref-type="bibr">Cidis Meltzer <italic>et al</italic>, 2001</xref>, <xref rid="R37" ref-type="bibr">Moller <italic>et al</italic>, 2007</xref>, <xref rid="R67" ref-type="bibr">Tauscher <italic>et al</italic>, 2001</xref>), the magnitude of these reported effects is not sufficient to explain our findings, given the small difference in age between groups. There was a higher incidence of comorbid anxiety disorders among AN currently depressed subjects than remitted depressed subjects. While panic disorder and social anxiety disorder have been associated with lower 5-HT<sub>1A</sub> receptor binding (<xref rid="R30" ref-type="bibr">Lanzenberger <italic>et al</italic>, 2007</xref>, <xref rid="R40" ref-type="bibr">Nash <italic>et al</italic>, 2008</xref>, <xref rid="R43" ref-type="bibr">Neumeister <italic>et al</italic>, 2004</xref>), the small number of subjects with these comorbidities in the current sample prevented statistical analysis of such effects.</p>
              <p id="P34">This study has some limitations. It has a modest sample size of remitted depressed subjects. In addition, remitted depressed subjects reported past antidepressant-exposure, but this exposure was on average 3 years earlier, and hence is unlikely to have had persistent effects on 5-HT<sub>1A</sub> BP<sub>F</sub>. Any residual effects of past antidepressant medication on 5-HT<sub>1A</sub> receptors among remitted depressed subjects would be expected to lead to <italic>lower</italic> 5-HT<sub>1A</sub> BP<sub>F</sub> (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>), and thereby an <italic>underestimation</italic> of the magnitude of the difference we report between remitted depressed subjects and healthy controls. Remitted depressed subjects were recruited once they were already in sustained remission; their clinical history was therefore based on subjects’ retrospective reports of prior depressive episodes and symptoms. Future studies could identify subjects prospectively by following individuals assessed during a current MDE into periods of sustained remission. Finally, PET data from some healthy controls and all AN depressed subjects in comparator groups were drawn from a previous study (<xref rid="R51" ref-type="bibr">Parsey <italic>et al</italic>, 2006d</xref>). This is unlikely to have influenced the results reported here, as PET acquisition, processing, and data analysis did not differ between groups. There was no difference in 5-HT<sub>1A</sub> BP<sub>F</sub> between the first and second cohorts of controls, making temporal drift an unlikely explanation of our findings. While T1-weighted MRIs used for identification of ROIs were performed on 1.5T and 3T cameras, we observed no difference in the volume of a representative ROI, the dorsolateral prefrontal cortex, as a function of MRI camera (comparison among remitted depressed: t=0.90, df=13, p=0.38; comparison among healthy controls: t=1.08, df=49, p=0.29). Similarly, regional [<sup>11</sup>C]WAY-100635 V<sub>T</sub> values did not differ as a function of MRI camera when comparing age- and sex- matched controls considering all ROI’s (F=0.004, df= 1,11.87, p=0.95).</p>
              <p id="P35">5-HT<sub>1A</sub> BP<sub>F</sub> may serve as a biological marker in populations at-risk for the development of MDD (including those with a family history of mood disorder), which could be used for the purposes of screening and primary prevention. Future studies should examine genetic and nongenetic causes of elevated 5-HT<sub>1A</sub> receptor binding potential in MDD, its relationship to treatment outcome, and the effect of treatment on binding.</p>
              <p id="P36">In summary, this study provides evidence of persistently elevated 5-HT<sub>1A</sub> receptor binding potential among subjects with MDD in sustained remission, consistent with a trait serotonergic abnormality in MDD. Apparent discrepancies between this finding and previously published findings are reconciled through a close analysis of PET acquisition and analysis methodologies.</p>
            </sec>
          </body>
          <back>
            <ack id="S21">
              <p>We would like to thank the staff of the Brain Imaging Division and Clinical Evaluation Core of The Department of Molecular Imaging and Neuropathology, as well as the Kreitchman PET Center. Funding for this study was provided by NIMH Grants MH01997-05 and MH40695-17 as well as NARSAD.</p>
              <p>
                <bold>Disclosure/Conflicts of Interest</bold>
              </p>
              <p>The authors declare that this work was funded by NIMH Grants MH01997-05 and MH40695-17 as well as NARSAD, and deny any conflicts of interest related to the subject of this report.</p>
              <p>Dr. Miller has received financial compensation for psychiatric evaluations of subjects enrolled in medication studies sponsored by Pfizer and Orexigen Therapeutics, unrelated to the current manuscript.</p>
              <p>Ms. Brennan reports no biomedical financial interests or potential conflicts of interest.</p>
              <p>Dr. Ogden reports no biomedical financial interests or potential conflicts of interest.</p>
              <p>Dr. Oquendo received financial compensation from Pfizer for the safety evaluation of a clinical facility, and was the recipient of a grant from Eli Lilly to support a year of salary for the Lilly Suicide Scholar, Enrique Baca-Garcia, M.D., Ph.D, both unrelated to the current manuscript.</p>
              <p>Dr. Sullivan has been on speakers’ bureaus for Pfizer and GSK, has consulted for Jazz Pharmaceuticals and Krele Pharmaceuticals, previously owned stock in Pfizer, and has a patent application for use of tianeptine, all unrelated to the current manuscript.</p>
              <p>Dr. Mann is principal investigator on PET Imaging grants from GSK and Novartis unrelated to the current manuscript.</p>
              <p>Dr. Parsey has received PET Imaging grants from Novartis Pharmaceuticals, Sepracor, Inc., Pfizer, and Eli Lilly Company, unrelated to the current manuscript.</p>
            </ack>
            <ref-list>
              <ref id="R1">
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aghajanian</surname>
                      <given-names>GK</given-names>
                    </name>
                    <name>
                      <surname>Sanders-Bush</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Serotonin</article-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Davis</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Charney</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Coyle</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Nemeroff</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <source>Neuropsychopharmacology - The Fifth Generation of Progress</source>
                  <publisher-name>Lipincott Williams &amp; Wilkins</publisher-name>
                  <publisher-loc>Philadelphia</publisher-loc>
                  <fpage>15</fpage>
                  <lpage>34</lpage>
                </element-citation>
              </ref>
              <ref id="R2">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Albert</surname>
                      <given-names>PR</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>A Functional Promoter Polymorphism of the 5-HT1A Receptor Gene: Association with Depression and Completed Suicide</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>55</volume>
                  <fpage>46S</fpage>
                </element-citation>
              </ref>
              <ref id="R3">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ashburner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Friston</surname>
                      <given-names>KJ</given-names>
                    </name>
                  </person-group>
                  <year>1999</year>
                  <article-title>Nonlinear spatial normalization using basis functions</article-title>
                  <source>Hum Brain Mapp</source>
                  <volume>7</volume>
                  <fpage>254</fpage>
                  <lpage>266</lpage>
                  <pub-id pub-id-type="pmid">10408769</pub-id>
                </element-citation>
              </ref>
              <ref id="R4">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ashburner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Friston</surname>
                      <given-names>KJ</given-names>
                    </name>
                  </person-group>
                  <year>2005</year>
                  <article-title>Unified segmentation</article-title>
                  <source>NeuroImage</source>
                  <volume>26</volume>
                  <fpage>839</fpage>
                  <lpage>851</lpage>
                  <pub-id pub-id-type="pmid">15955494</pub-id>
                </element-citation>
              </ref>
              <ref id="R5">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Basso</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Bornstein</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1999</year>
                  <article-title>Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task</article-title>
                  <source>Neuropsychology</source>
                  <volume>13</volume>
                  <fpage>557</fpage>
                  <lpage>563</lpage>
                  <pub-id pub-id-type="pmid">10527064</pub-id>
                </element-citation>
              </ref>
              <ref id="R6">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beck</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Ward</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Mendelson</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mock</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Erbauh</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>1961</year>
                  <article-title>An inventory for measuring depression</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>4</volume>
                  <fpage>53</fpage>
                  <lpage>63</lpage>
                </element-citation>
              </ref>
              <ref id="R7">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beck</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Weissman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lester</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Trexler</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <year>1974</year>
                  <article-title>The measurement of pessimism: the hopelessness scale</article-title>
                  <source>J Consult Clin Psychol</source>
                  <volume>42</volume>
                  <fpage>861</fpage>
                  <lpage>865</lpage>
                  <pub-id pub-id-type="pmid">4436473</pub-id>
                </element-citation>
              </ref>
              <ref id="R8">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bhagwagar</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Cowen</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>‘It’s not over when it’s over’: persistent neurobiological abnormalities in recovered depressed patients</article-title>
                  <source>Psychol Med</source>
                  <volume>38</volume>
                  <fpage>307</fpage>
                  <lpage>313</lpage>
                  <pub-id pub-id-type="pmid">18444278</pub-id>
                </element-citation>
              </ref>
              <ref id="R9">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bhagwagar</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Rabiner</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Sargent</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Grasby</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Cowen</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635</article-title>
                  <source>Molecular psychiatry</source>
                  <volume>9</volume>
                  <fpage>386</fpage>
                  <lpage>392</lpage>
                  <pub-id pub-id-type="pmid">15042104</pub-id>
                </element-citation>
              </ref>
              <ref id="R10">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bhagwagar</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Whale</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cowen</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>State and trait abnormalities in serotonin function in major depression</article-title>
                  <source>Br J Psychiatry</source>
                  <volume>180</volume>
                  <fpage>24</fpage>
                  <lpage>28</lpage>
                  <pub-id pub-id-type="pmid">11772847</pub-id>
                </element-citation>
              </ref>
              <ref id="R11">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boldrini</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Underwood</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides</article-title>
                  <source>J Psychiatr Res</source>
                  <volume>42</volume>
                  <fpage>433</fpage>
                  <lpage>442</lpage>
                  <pub-id pub-id-type="pmid">17574270</pub-id>
                </element-citation>
              </ref>
              <ref id="R12">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brix</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Zaers</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Adam</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Bellemann</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Ostertag</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Trojan</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Haberkorn</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Doll</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Oberdorfer</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Lorenz</surname>
                      <given-names>WJ</given-names>
                    </name>
                  </person-group>
                  <year>1997</year>
                  <article-title>Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association</article-title>
                  <source>J Nucl Med</source>
                  <volume>38</volume>
                  <fpage>1614</fpage>
                  <lpage>1623</lpage>
                  <pub-id pub-id-type="pmid">9379202</pub-id>
                </element-citation>
              </ref>
              <ref id="R13">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cahir</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ardis</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>GP</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>SJ</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat</article-title>
                  <source>Psychopharmacology</source>
                  <volume>190</volume>
                  <fpage>497</fpage>
                  <lpage>506</lpage>
                  <pub-id pub-id-type="pmid">17124620</pub-id>
                </element-citation>
              </ref>
              <ref id="R14">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cidis Meltzer</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Mathis</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Lopresti</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Greer</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Villemagne</surname>
                      <given-names>VL</given-names>
                    </name>
                    <name>
                      <surname>Holt</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Mason</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Houck</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>CF</given-names>
                      <suffix>3rd</suffix>
                    </name>
                    <name>
                      <surname>DeKosky</surname>
                      <given-names>ST</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Gender-specific aging effects on the serotonin 1A receptor</article-title>
                  <source>Brain Res</source>
                  <volume>895</volume>
                  <fpage>9</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="pmid">11259754</pub-id>
                </element-citation>
              </ref>
              <ref id="R15">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Holt</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Greer</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Gautier</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Mathis</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <year>1999</year>
                  <article-title>PET imaging of serotonin 1A receptor binding in depression</article-title>
                  <source>Biological psychiatry</source>
                  <volume>46</volume>
                  <fpage>1375</fpage>
                  <lpage>1387</lpage>
                  <pub-id pub-id-type="pmid">10578452</pub-id>
                </element-citation>
              </ref>
              <ref id="R16">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Thase</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Moses-Kolko</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Mathis</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Serotonin-1A receptor imaging in recurrent depression: replication and literature review</article-title>
                  <source>Nuclear medicine and biology</source>
                  <volume>34</volume>
                  <fpage>865</fpage>
                  <lpage>877</lpage>
                  <pub-id pub-id-type="pmid">17921037</pub-id>
                </element-citation>
              </ref>
              <ref id="R17">
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duvernoy</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>1991</year>
                  <source>The human brain Surface, three-dimensional sectional anatomy and MRI</source>
                  <publisher-name>Sringer-Verlag Wien</publisher-name>
                  <publisher-loc>New York</publisher-loc>
                </element-citation>
              </ref>
              <ref id="R18">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Endicott</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Fleiss</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>1976</year>
                  <article-title>The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>33</volume>
                  <fpage>766</fpage>
                  <lpage>771</lpage>
                  <pub-id pub-id-type="pmid">938196</pub-id>
                </element-citation>
              </ref>
              <ref id="R19">
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>First</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Gibbon</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>1995</year>
                  <source>Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P, Version 2.0)</source>
                  <publisher-name>Biometrics Research Dept., New York State Psychiatric Institute</publisher-name>
                  <publisher-loc>New York</publisher-loc>
                </element-citation>
              </ref>
              <ref id="R20">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Flory</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Manuck</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Muldoon</surname>
                      <given-names>MF</given-names>
                    </name>
                  </person-group>
                  <year>1998</year>
                  <article-title>Recovery from major depression is not associated with normalization of serotonergic function</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>43</volume>
                  <fpage>320</fpage>
                  <lpage>326</lpage>
                  <pub-id pub-id-type="pmid">9513746</pub-id>
                </element-citation>
              </ref>
              <ref id="R21">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gunther</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Liebscher</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Jahkel</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Oehler</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Effects of chronic citalopram treatment on 5-HT(1A) and 5-HT(2A) receptors in group- and isolation-housed mice</article-title>
                  <source>Eur J Pharmacol</source>
                </element-citation>
              </ref>
              <ref id="R22">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>1960</year>
                  <article-title>A rating scale for depression</article-title>
                  <source>J Neurol Neurosurg Psych</source>
                  <volume>23</volume>
                  <fpage>56</fpage>
                  <lpage>62</lpage>
                </element-citation>
              </ref>
              <ref id="R23">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hirvonen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Karlsson</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Kajander</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lepola</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Markkula</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rasi-Hakala</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Nagren</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Salminen</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Hietala</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635</article-title>
                  <source>Int J Neuropsychopharmacol</source>
                  <volume>11</volume>
                  <fpage>465</fpage>
                  <lpage>476</lpage>
                  <pub-id pub-id-type="pmid">17971260</pub-id>
                </element-citation>
              </ref>
              <ref id="R24">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jenkinson</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>A global optimisation method for robust affine registration of brain images</article-title>
                  <source>Medical image analysis</source>
                  <volume>5</volume>
                  <fpage>143</fpage>
                  <lpage>156</lpage>
                  <pub-id pub-id-type="pmid">11516708</pub-id>
                </element-citation>
              </ref>
              <ref id="R25">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jindal</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Thase</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Fasiczka</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Friedman</surname>
                      <given-names>ES</given-names>
                    </name>
                    <name>
                      <surname>Buysse</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>51</volume>
                  <fpage>230</fpage>
                  <lpage>236</lpage>
                  <pub-id pub-id-type="pmid">11839366</pub-id>
                </element-citation>
              </ref>
              <ref id="R26">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kates</surname>
                      <given-names>WR</given-names>
                    </name>
                    <name>
                      <surname>Abrams</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Kaufmann</surname>
                      <given-names>WE</given-names>
                    </name>
                    <name>
                      <surname>Breiter</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Reiss</surname>
                      <given-names>AL</given-names>
                    </name>
                  </person-group>
                  <year>1997</year>
                  <article-title>Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome</article-title>
                  <source>Psychiat Res Neuroimag</source>
                  <volume>75</volume>
                  <fpage>31</fpage>
                  <lpage>48</lpage>
                </element-citation>
              </ref>
              <ref id="R27">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Killiany</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Moss</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Nicholson</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Jolesz</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sandor</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <year>1997</year>
                  <article-title>An interactive procedure for extracting features of the brain from magnetic resonance images: The lobes</article-title>
                  <source>Human Brain Mapping</source>
                  <volume>5</volume>
                  <fpage>355</fpage>
                  <lpage>363</lpage>
                  <pub-id pub-id-type="pmid">20408240</pub-id>
                </element-citation>
              </ref>
              <ref id="R28">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Ehlers</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Grochocinski</surname>
                      <given-names>VJ</given-names>
                    </name>
                    <name>
                      <surname>McEachran</surname>
                      <given-names>AB</given-names>
                    </name>
                  </person-group>
                  <year>1991</year>
                  <article-title>EEG sleep profiles and recurrent depression</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>30</volume>
                  <fpage>641</fpage>
                  <lpage>655</lpage>
                  <pub-id pub-id-type="pmid">1958764</pub-id>
                </element-citation>
              </ref>
              <ref id="R29">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lammertsma</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Hume</surname>
                      <given-names>SP</given-names>
                    </name>
                  </person-group>
                  <year>1996</year>
                  <article-title>Simplified reference tissue model for PET receptor studies</article-title>
                  <source>Neuroimage</source>
                  <volume>4</volume>
                  <fpage>153</fpage>
                  <lpage>158</lpage>
                  <pub-id pub-id-type="pmid">9345505</pub-id>
                </element-citation>
              </ref>
              <ref id="R30">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lanzenberger</surname>
                      <given-names>RR</given-names>
                    </name>
                    <name>
                      <surname>Mitterhauser</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Spindelegger</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Wadsak</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Klein</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Mien</surname>
                      <given-names>LK</given-names>
                    </name>
                    <name>
                      <surname>Holik</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Attarbaschi</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Mossaheb</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Sacher</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Geiss-Granadia</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Kletter</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kasper</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Tauscher</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Reduced serotonin-1A receptor binding in social anxiety disorder</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>61</volume>
                  <fpage>1081</fpage>
                  <lpage>1089</lpage>
                  <pub-id pub-id-type="pmid">16979141</pub-id>
                </element-citation>
              </ref>
              <ref id="R31">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Laruelle</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>van Dyck</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Abi-Dargham</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Zea-Ponce</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Zoghbi</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Charney</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Baldwin</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Hoffer</surname>
                      <given-names>PB</given-names>
                    </name>
                    <name>
                      <surname>Kung</surname>
                      <given-names>HF</given-names>
                    </name>
                    <name>
                      <surname>Innis</surname>
                      <given-names>RB</given-names>
                    </name>
                  </person-group>
                  <year>1994</year>
                  <article-title>Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects</article-title>
                  <source>Journal of Nuclear Medicine</source>
                  <volume>35</volume>
                  <fpage>743</fpage>
                  <lpage>754</lpage>
                  <pub-id pub-id-type="pmid">8176454</pub-id>
                </element-citation>
              </ref>
              <ref id="R32">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Le François</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Czesak</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Steubl</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Albert</surname>
                      <given-names>PR</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Transcriptional regulation at a HTR1A polymorphism associated with mental illness</article-title>
                  <source>Neuropharmacology</source>
                  <volume>55</volume>
                  <fpage>977</fpage>
                  <lpage>985</lpage>
                  <pub-id pub-id-type="pmid">18639564</pub-id>
                </element-citation>
              </ref>
              <ref id="R33">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lemonde</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Turecki</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Bakish</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Du</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Hrdina</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Bown</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Sequeira</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kushwaha</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Basak</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ou</surname>
                      <given-names>XM</given-names>
                    </name>
                    <name>
                      <surname>Albert</surname>
                      <given-names>PR</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide</article-title>
                  <source>J Neurosci</source>
                  <volume>23</volume>
                  <fpage>8788</fpage>
                  <lpage>8799</lpage>
                  <pub-id pub-id-type="pmid">14507979</pub-id>
                </element-citation>
              </ref>
              <ref id="R34">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meltzer</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Mathis</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Butters</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Ziolko</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Moses-Kolko</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Mazumdar</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mulsant</surname>
                      <given-names>BH</given-names>
                    </name>
                    <name>
                      <surname>Houck</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Lopresti</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Weissfeld</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>CF</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>Serotonin 1A receptor binding and treatment response in late-life depression</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>29</volume>
                  <fpage>2258</fpage>
                  <lpage>2265</lpage>
                  <pub-id pub-id-type="pmid">15483563</pub-id>
                </element-citation>
              </ref>
              <ref id="R35">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miller</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder</article-title>
                  <source>J Psychiatr Res</source>
                  <volume>42</volume>
                  <fpage>1137</fpage>
                  <lpage>1144</lpage>
                  <pub-id pub-id-type="pmid">18331740</pub-id>
                </element-citation>
              </ref>
              <ref id="R36">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mintun</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Raichle</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Kilbourn</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Wooten</surname>
                      <given-names>GF</given-names>
                    </name>
                    <name>
                      <surname>Welch</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <year>1984</year>
                  <article-title>A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography</article-title>
                  <source>Ann Neurol</source>
                  <volume>15</volume>
                  <fpage>217</fpage>
                  <lpage>227</lpage>
                  <pub-id pub-id-type="pmid">6609679</pub-id>
                </element-citation>
              </ref>
              <ref id="R37">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moller</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jakobsen</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gjedde</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>32</volume>
                  <fpage>1707</fpage>
                  <lpage>1714</lpage>
                  <pub-id pub-id-type="pmid">17251909</pub-id>
                </element-citation>
              </ref>
              <ref id="R38">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moses-Kolko</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Thase</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Meltzer</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Mathis</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Bogers</surname>
                      <given-names>WD</given-names>
                    </name>
                    <name>
                      <surname>Berman</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Houck</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>TN</given-names>
                    </name>
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                  </person-group>
                  <year>2007a</year>
                  <article-title>Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635</article-title>
                  <source>Synapse</source>
                  <volume>61</volume>
                  <fpage>523</fpage>
                  <lpage>530</lpage>
                  <pub-id pub-id-type="pmid">17447260</pub-id>
                </element-citation>
              </ref>
              <ref id="R39">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moses-Kolko</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Wisner</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Berga</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Hanusa</surname>
                      <given-names>BH</given-names>
                    </name>
                    <name>
                      <surname>Loucks</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Meltzer</surname>
                      <given-names>CC</given-names>
                    </name>
                  </person-group>
                  <year>2007b</year>
                  <article-title>Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study</article-title>
                  <source>Fertil Steril</source>
                </element-citation>
              </ref>
              <ref id="R40">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nash</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Sargent</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Rabiner</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Hood</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Argyropoulos</surname>
                      <given-names>SV</given-names>
                    </name>
                    <name>
                      <surname>Potokar</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Grasby</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Nutt</surname>
                      <given-names>DJ</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study</article-title>
                  <source>Br J Psychiatry</source>
                  <volume>193</volume>
                  <fpage>229</fpage>
                  <lpage>234</lpage>
                  <pub-id pub-id-type="pmid">18757983</pub-id>
                </element-citation>
              </ref>
              <ref id="R41">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Naudon</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>El Yacoubi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Vaugeois</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Leroux-Nicollet</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Costentin</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness</article-title>
                  <source>Brain Res</source>
                  <volume>936</volume>
                  <fpage>68</fpage>
                  <pub-id pub-id-type="pmid">11988231</pub-id>
                </element-citation>
              </ref>
              <ref id="R42">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Navines</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Gomez-Gil</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Martin-Santos</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>de Osaba</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Escolar</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Gasto</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Hormonal response to buspirone is not impaired in major depression</article-title>
                  <source>Human psychopharmacology</source>
                  <volume>22</volume>
                  <fpage>389</fpage>
                  <lpage>395</lpage>
                  <pub-id pub-id-type="pmid">17563921</pub-id>
                </element-citation>
              </ref>
              <ref id="R43">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Neumeister</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bain</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Nugent</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Carson</surname>
                      <given-names>RE</given-names>
                    </name>
                    <name>
                      <surname>Bonne</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Luckenbaugh</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Eckelman</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Herscovitch</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Charney</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>Reduced serotonin type 1A receptor binding in panic disorder</article-title>
                  <source>J Neurosci</source>
                  <volume>24</volume>
                  <fpage>589</fpage>
                  <lpage>591</lpage>
                  <pub-id pub-id-type="pmid">14736842</pub-id>
                </element-citation>
              </ref>
              <ref id="R44">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Tarpey</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <year>2006</year>
                  <article-title>Estimation in regression models with externally estimated parameters</article-title>
                  <source>Biostatistics (Oxford, England)</source>
                  <volume>7</volume>
                  <fpage>115</fpage>
                  <lpage>129</lpage>
                </element-citation>
              </ref>
              <ref id="R45">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Hastings</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>XZ</given-names>
                    </name>
                    <name>
                      <surname>Goldman</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>64</volume>
                  <fpage>201</fpage>
                  <lpage>208</lpage>
                  <pub-id pub-id-type="pmid">17283287</pub-id>
                </element-citation>
              </ref>
              <ref id="R46">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Olvet</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>John Mann</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2005a</year>
                  <article-title>Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <volume>25</volume>
                  <fpage>785</fpage>
                  <lpage>793</lpage>
                  <pub-id pub-id-type="pmid">15716853</pub-id>
                </element-citation>
              </ref>
              <ref id="R47">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Belanger</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>GM</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Stabin</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <year>2005b</year>
                  <article-title>Biodistribution and Radiation Dosimetry of 11C-WAY100,635 in Humans</article-title>
                  <source>J Nucl Med</source>
                  <volume>46</volume>
                  <fpage>614</fpage>
                  <lpage>619</lpage>
                  <pub-id pub-id-type="pmid">15809484</pub-id>
                </element-citation>
              </ref>
              <ref id="R48">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Hastings</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Goldman</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Arcement</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <year>2006a</year>
                  <article-title>Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain</article-title>
                  <source>Am J Psychiatry</source>
                  <volume>163</volume>
                  <fpage>48</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="pmid">16390888</pub-id>
                </element-citation>
              </ref>
              <ref id="R49">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Hastings</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Arcement</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <year>2006b</year>
                  <article-title>Lower serotonin transporter binding potential in the human brain during major depressive episodes</article-title>
                  <source>Am J Psychiatry</source>
                  <volume>163</volume>
                  <fpage>52</fpage>
                  <lpage>58</lpage>
                  <pub-id pub-id-type="pmid">16390889</pub-id>
                </element-citation>
              </ref>
              <ref id="R50">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Olvet</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <year>2006c</year>
                  <article-title>Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>31</volume>
                  <fpage>1745</fpage>
                  <lpage>1749</lpage>
                  <pub-id pub-id-type="pmid">16395308</pub-id>
                </element-citation>
              </ref>
              <ref id="R51">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Olvet</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <year>2006d</year>
                  <article-title>Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>59</volume>
                  <fpage>106</fpage>
                  <lpage>113</lpage>
                  <pub-id pub-id-type="pmid">16154547</pub-id>
                </element-citation>
              </ref>
              <ref id="R52">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Arango</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT(1A) receptor binding potential measured by PET using [C-11]WAY-100635</article-title>
                  <source>Brain Res</source>
                  <volume>954</volume>
                  <fpage>173</fpage>
                  <lpage>182</lpage>
                  <pub-id pub-id-type="pmid">12414100</pub-id>
                </element-citation>
              </ref>
              <ref id="R53">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hwang</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Abi-Dargham</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Mawlawi</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>NN</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Laruelle</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2000</year>
                  <article-title>Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <volume>20</volume>
                  <fpage>1111</fpage>
                  <lpage>1133</lpage>
                  <pub-id pub-id-type="pmid">10908045</pub-id>
                </element-citation>
              </ref>
              <ref id="R54">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rabiner</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Messa</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Sargent</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Husted-Kjaer</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Montgomery</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lawrence</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Bench</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Gunn</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>Cowen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Grasby</surname>
                      <given-names>PM</given-names>
                    </name>
                  </person-group>
                  <year>2002a</year>
                  <article-title>A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables</article-title>
                  <source>Neuroimage</source>
                  <volume>15</volume>
                  <fpage>620</fpage>
                  <lpage>632</lpage>
                  <pub-id pub-id-type="pmid">11848705</pub-id>
                </element-citation>
              </ref>
              <ref id="R55">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rabiner</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Wilkins</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Turkheimer</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Gunn</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>Udo de Haes</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>de Vries</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Grasby</surname>
                      <given-names>PM</given-names>
                    </name>
                  </person-group>
                  <year>2002b</year>
                  <article-title>5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzi sothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans</article-title>
                  <source>J Pharmacol Exp Ther</source>
                  <volume>301</volume>
                  <fpage>1144</fpage>
                  <lpage>1150</lpage>
                  <pub-id pub-id-type="pmid">12023549</pub-id>
                </element-citation>
              </ref>
              <ref id="R56">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ruhe</surname>
                      <given-names>HG</given-names>
                    </name>
                    <name>
                      <surname>Mason</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Schene</surname>
                      <given-names>AH</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies</article-title>
                  <source>Molecular psychiatry</source>
                  <volume>12</volume>
                  <fpage>331</fpage>
                  <lpage>359</lpage>
                  <pub-id pub-id-type="pmid">17389902</pub-id>
                </element-citation>
              </ref>
              <ref id="R57">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sargent</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Kjaer</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Bench</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Rabiner</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Messa</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gunn</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>Grasby</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Cowen</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <year>2000</year>
                  <article-title>Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment</article-title>
                  <source>Archives of general psychiatry</source>
                  <volume>57</volume>
                  <fpage>174</fpage>
                  <lpage>180</lpage>
                  <pub-id pub-id-type="pmid">10665620</pub-id>
                </element-citation>
              </ref>
              <ref id="R58">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shively</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Friedman</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Gage</surname>
                      <given-names>HD</given-names>
                    </name>
                    <name>
                      <surname>Bounds</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Brown-Proctor</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Blair</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Henderson</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Buchheimer</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <year>2006</year>
                  <article-title>Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>63</volume>
                  <fpage>396</fpage>
                  <lpage>403</lpage>
                  <pub-id pub-id-type="pmid">16585468</pub-id>
                </element-citation>
              </ref>
              <ref id="R59">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shively</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Willard</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Davenport</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Friedman</surname>
                      <given-names>DP</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>5HT1a receptor binding in the hippocampus of behaviorally depressed female cynomolgus macaques (Macaca fascicularis)</article-title>
                  <source>Society for Neuroscience</source>
                </element-citation>
              </ref>
              <ref id="R60">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Laruelle</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers</article-title>
                  <source>Nuclear medicine and biology</source>
                  <volume>28</volume>
                  <fpage>595</fpage>
                  <lpage>608</lpage>
                  <pub-id pub-id-type="pmid">11516703</pub-id>
                </element-citation>
              </ref>
              <ref id="R61">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>Laruelle</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2000</year>
                  <article-title>Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions</article-title>
                  <comment>In Process Citation</comment>
                  <source>Nuclear medicine and biology</source>
                  <volume>27</volume>
                  <fpage>487</fpage>
                  <lpage>492</lpage>
                  <pub-id pub-id-type="pmid">10962256</pub-id>
                </element-citation>
              </ref>
              <ref id="R62">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Fast robust automated brain extraction</article-title>
                  <source>Hum Brain Mapp</source>
                  <volume>17</volume>
                  <fpage>143</fpage>
                  <lpage>155</lpage>
                  <pub-id pub-id-type="pmid">12391568</pub-id>
                </element-citation>
              </ref>
              <ref id="R63">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spindelegger</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Lanzenberger</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wadsak</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Mien</surname>
                      <given-names>LK</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Mitterhauser</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Moser</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Holik</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pezawas</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Kletter</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kasper</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders</article-title>
                  <source>Mol Psychiatry</source>
                </element-citation>
              </ref>
              <ref id="R64">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stockmeier</surname>
                      <given-names>CA</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter</article-title>
                  <source>J Psychiatr Res</source>
                  <volume>37</volume>
                  <fpage>357</fpage>
                  <lpage>373</lpage>
                  <pub-id pub-id-type="pmid">12849929</pub-id>
                </element-citation>
              </ref>
              <ref id="R65">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>GM</given-names>
                    </name>
                    <name>
                      <surname>Oquendo</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Van Heertum</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Parsey</surname>
                      <given-names>RV</given-names>
                    </name>
                  </person-group>
                  <year>2005</year>
                  <article-title>Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>58</volume>
                  <fpage>947</fpage>
                  <lpage>954</lpage>
                  <pub-id pub-id-type="pmid">16039621</pub-id>
                </element-citation>
              </ref>
              <ref id="R66">
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Talairach</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Tournoux</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <year>1988</year>
                  <article-title>Co-planar stereotactic atlas of the human brain</article-title>
                  <source>Three-dimensional proportional system: an approach of cerebral imaging</source>
                  <publisher-name>Theime Medical Publisher</publisher-name>
                  <publisher-loc>New York</publisher-loc>
                </element-citation>
              </ref>
              <ref id="R67">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tauscher</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Verhoeff</surname>
                      <given-names>NP</given-names>
                    </name>
                    <name>
                      <surname>Christensen</surname>
                      <given-names>BK</given-names>
                    </name>
                    <name>
                      <surname>Hussey</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Kecojevic</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Javanmard</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kasper</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kapur</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>24</volume>
                  <fpage>522</fpage>
                  <lpage>530</lpage>
                  <pub-id pub-id-type="pmid">11282252</pub-id>
                </element-citation>
              </ref>
              <ref id="R68">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thase</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <year>1992</year>
                  <article-title>Long-term treatments of recurrent depressive disorders</article-title>
                  <source>J Clin Psychiatry</source>
                  <volume>53</volume>
                  <issue>Suppl</issue>
                  <fpage>32</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="pmid">1522078</pub-id>
                </element-citation>
              </ref>
              <ref id="R69">
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thase</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Buysse</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Simons</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>McEachran</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Rashid</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Grochocinski</surname>
                      <given-names>VJ</given-names>
                    </name>
                  </person-group>
                  <year>1995</year>
                  <article-title>Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>38</volume>
                  <fpage>506</fpage>
                  <lpage>515</lpage>
                  <pub-id pub-id-type="pmid">8562662</pub-id>
                </element-citation>
              </ref>
              <ref id="R70">
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Watson</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Newport</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Casey</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <year>1995</year>
                  <article-title>A single scatter simulation technique for scatter correction in 3D PET</article-title>
                  <source>Fully three-dimensional image reconstruction in radiology and nuclear medicine</source>
                  <publisher-name>Aix-les-bains</publisher-name>
                  <publisher-loc>France</publisher-loc>
                  <fpage>215</fpage>
                  <lpage>219</lpage>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="F1" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Remitted depressed subjects have higher serotonin 1A receptor binding potential (BP<sub>F</sub>) than healthy controls and do not differ significantly from antidepressant-naïve currently depressed subjects, considering all regions simultaneously. Regions: RN, raphe nuclei; VPFC, ventral prefrontal cortex; MPFC, medial PFC; DLPFC, dorsolateral PFC; ACN, anterior cingulate; CIN, cingulate cortex (posterior to ACN); AMY, amygdala; HIP, hippocampus; PHG, parahippocampal gyrus; INS, insular cortex; TEM, temporal cortex; PAR, parietal cortex; OCC, occipital cortex. Linear mixed effects model comparing remitted depressed to controls: F=4.99, df=1,90, p=0.028. Comparing remitted depressed to currently depressed: F=0.065, df=1,90, p=0.80. Bar heights indicate weighted mean BP<sub>F</sub> for each ROI; error bars represent the corresponding equivalent of the standard deviation of the weighted mean for each ROI.</p>
              </caption>
              <graphic xlink:href="nihms113592f1"/>
            </fig>
            <fig id="F2" position="float">
              <label>Figure 2</label>
              <caption>
                <p>Chronological model of serotonin 1A receptor binding potential over the life span among subjects with major depressive disorder as compared to healthy controls.</p>
              </caption>
              <graphic xlink:href="nihms113592f2"/>
            </fig>
            <table-wrap id="T1" position="float" orientation="landscape">
              <label>Table 1</label>
              <caption>
                <p>Clinical and Demographic Characteristics of the Sample</p>
              </caption>
              <table frame="box" rules="all">
                <thead>
                  <tr>
                    <th align="left" rowspan="1" colspan="1"/>
                    <th align="center" valign="top" rowspan="1" colspan="1">Controls (n=51)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Remitted depressed (n=15)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Antidepressant-naive (AN) currently depressed (n=13)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Remitted Depressed vs. Controls</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Remitted Depressed vs. AN Currently Depressed</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">
                      <bold>Continuous Variables</bold>
                    </td>
                    <td align="center" colspan="3" rowspan="1">mean (S.D.)</td>
                    <td align="center" colspan="2" rowspan="1">p-value (2-tailed t-test)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Age</td>
                    <td align="center" rowspan="1" colspan="1">37.4±14.5</td>
                    <td align="center" rowspan="1" colspan="1">31.8±10.9</td>
                    <td align="center" rowspan="1" colspan="1">35.9±12.3</td>
                    <td align="center" rowspan="1" colspan="1">0.17</td>
                    <td align="center" rowspan="1" colspan="1">0.36</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">24-Item Hamilton Depression Rating Scale</td>
                    <td align="center" rowspan="1" colspan="1">0.7±1.0</td>
                    <td align="center" rowspan="1" colspan="1">3.5±2.3</td>
                    <td align="center" rowspan="1" colspan="1">25.5±8.0</td>
                    <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                    <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Beck Depression Inventory</td>
                    <td align="center" rowspan="1" colspan="1">1.6±2.5</td>
                    <td align="center" rowspan="1" colspan="1">2.6±2.9</td>
                    <td align="center" rowspan="1" colspan="1">26.9±8.1</td>
                    <td align="center" rowspan="1" colspan="1">0.19</td>
                    <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Global Assessment Scale</td>
                    <td align="center" rowspan="1" colspan="1">90.1±4.6</td>
                    <td align="center" rowspan="1" colspan="1">86.3±7.5</td>
                    <td align="center" rowspan="1" colspan="1">52.5±12.8</td>
                    <td align="center" rowspan="1" colspan="1">0.02</td>
                    <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Beck Hopelessness Scale</td>
                    <td align="center" rowspan="1" colspan="1">1.7±2.3</td>
                    <td align="center" rowspan="1" colspan="1">2.5±2.4</td>
                    <td align="center" rowspan="1" colspan="1">9.6±6.1</td>
                    <td align="center" rowspan="1" colspan="1">0.21</td>
                    <td align="center" rowspan="1" colspan="1">0.0003</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Brown Goodwin Aggression Scale</td>
                    <td align="center" rowspan="1" colspan="1">13.6±4.1</td>
                    <td align="center" rowspan="1" colspan="1">18.±4.1</td>
                    <td align="center" rowspan="1" colspan="1">16.3±4.6</td>
                    <td align="center" rowspan="1" colspan="1">0.0006</td>
                    <td align="center" rowspan="1" colspan="1">0.3</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Years of Education</td>
                    <td align="center" rowspan="1" colspan="1">16.6±2.9</td>
                    <td align="center" rowspan="1" colspan="1">16.1±1.0</td>
                    <td align="center" rowspan="1" colspan="1">13.3±4.2</td>
                    <td align="center" rowspan="1" colspan="1">0.49</td>
                    <td align="center" rowspan="1" colspan="1">0.02</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Age of Onset</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">15.9±4.8</td>
                    <td align="center" rowspan="1" colspan="1">22.1±11.4</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">0.069</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Median number of prior depressive episodes</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">3</td>
                    <td align="center" rowspan="1" colspan="1">4</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">0.88<xref rid="TFN1" ref-type="table-fn">*</xref></td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Length of current major depressive episode (days)</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">76.3±163.9</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Duration of remission (years)</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">2.9±1.8</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                    <td align="center" rowspan="1" colspan="1">N/A</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">
                      <bold>Categorical Variables</bold>
                    </td>
                    <td align="center" colspan="3" rowspan="1">N (%)</td>
                    <td align="center" colspan="2" rowspan="1">p-value (fisher’s exact)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Female</td>
                    <td align="center" rowspan="1" colspan="1">29 (56.9)</td>
                    <td align="center" rowspan="1" colspan="1">10 (66.7)</td>
                    <td align="center" rowspan="1" colspan="1">10 (76.9)</td>
                    <td align="center" rowspan="1" colspan="1">0.56</td>
                    <td align="center" rowspan="1" colspan="1">0.69</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Subjects with a history of prior suicide attempts</td>
                    <td align="center" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" rowspan="1" colspan="1">2 (13.3)</td>
                    <td align="center" rowspan="1" colspan="1">4 (30.8)</td>
                    <td align="center" rowspan="1" colspan="1">0.049</td>
                    <td align="center" rowspan="1" colspan="1">0.37</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Subjects with a history of major depression in first-degree relative</td>
                    <td align="center" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" rowspan="1" colspan="1">9 (60)</td>
                    <td align="center" rowspan="1" colspan="1">8 (61.5)</td>
                    <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                    <td align="center" rowspan="1" colspan="1">1</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Race/Ethnicity</td>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1">0.035</td>
                    <td align="center" rowspan="1" colspan="1">0.0006</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Asian</td>
                    <td align="center" rowspan="1" colspan="1">7 (13.7)</td>
                    <td align="center" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">African-American</td>
                    <td align="center" rowspan="1" colspan="1">8 (15.7)</td>
                    <td align="center" rowspan="1" colspan="1">1 (6.7)</td>
                    <td align="center" rowspan="1" colspan="1">1 (7.7)</td>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Caucasian</td>
                    <td align="center" rowspan="1" colspan="1">28 (54.9)</td>
                    <td align="center" rowspan="1" colspan="1">13 (86.7)</td>
                    <td align="center" rowspan="1" colspan="1">4 (30.8)</td>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Hispanic</td>
                    <td align="center" rowspan="1" colspan="1">8 (15.7)</td>
                    <td align="center" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" rowspan="1" colspan="1">7 (53.8)</td>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">&gt;1 Race</td>
                    <td align="center" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" rowspan="1" colspan="1">1 (6.7)</td>
                    <td align="center" rowspan="1" colspan="1">1 (7.7)</td>
                    <td align="center" rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <label>*</label>
                  <p>p-value associated with non-parametric Mann-Whitney test as some subjects reported “too numerous to count” prior depressive episodes.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="T2" position="float" orientation="landscape">
              <label>Table 2</label>
              <caption>
                <p>Genotypic and Allelic Frequencies of the C(-1019)G polymorphism in the 5-HT<sub>1A</sub> receptor gene.</p>
              </caption>
              <table frame="box" rules="all">
                <thead>
                  <tr>
                    <th align="left" rowspan="1" colspan="1"/>
                    <th align="center" rowspan="1" colspan="1"/>
                    <th align="center" colspan="3" rowspan="1">Genotypes n (%)</th>
                    <th align="center" colspan="2" rowspan="1">Alleles n (%)</th>
                  </tr>
                  <tr>
                    <th align="left" rowspan="1" colspan="1"/>
                    <th align="center" rowspan="1" colspan="1">n</th>
                    <th align="center" rowspan="1" colspan="1">CC</th>
                    <th align="center" rowspan="1" colspan="1">CG</th>
                    <th align="center" rowspan="1" colspan="1">GG</th>
                    <th align="center" rowspan="1" colspan="1">C</th>
                    <th align="center" rowspan="1" colspan="1">G</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Controls</td>
                    <td align="center" rowspan="1" colspan="1">50<xref rid="TFN2" ref-type="table-fn">*</xref></td>
                    <td align="center" rowspan="1" colspan="1">17 (34)</td>
                    <td align="center" rowspan="1" colspan="1">29 (58)</td>
                    <td align="center" rowspan="1" colspan="1">4 (8)</td>
                    <td align="center" rowspan="1" colspan="1">49 (59.8)</td>
                    <td align="center" rowspan="1" colspan="1">33 (40.2)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Remitted MDD</td>
                    <td align="center" rowspan="1" colspan="1">14<xref rid="TFN2" ref-type="table-fn">*</xref></td>
                    <td align="center" rowspan="1" colspan="1">3 (21.4)</td>
                    <td align="center" rowspan="1" colspan="1">9 (64.3)</td>
                    <td align="center" rowspan="1" colspan="1">2 (14.3)</td>
                    <td align="center" rowspan="1" colspan="1">15 (53.6)</td>
                    <td align="center" rowspan="1" colspan="1">13 (46.4)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Current MDD</td>
                    <td align="center" rowspan="1" colspan="1">28</td>
                    <td align="center" rowspan="1" colspan="1">6 (21.4)</td>
                    <td align="center" rowspan="1" colspan="1">11 (39.3)</td>
                    <td align="center" rowspan="1" colspan="1">11 (39.3)</td>
                    <td align="center" rowspan="1" colspan="1">23 (41.1)</td>
                    <td align="center" rowspan="1" colspan="1">33 (58.9)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN2">
                  <label>*</label>
                  <p>One control and one remitted MDD subject were not genotyped.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
